Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0422 Transporter Info | ||||
| Gene Name | SLC5A2 | ||||
| Transporter Name | Sodium/glucose cotransporter 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Sergliflozin A Drug Info | ||||
| Xenobiotic Type | Investigative Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 10177526 | ||||
| Docking Score | -9.879 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C20H24O7 | ||||
| Molecular Weight | 376.4 | ||||
| Canonical SMILES |
COC1=CC=C(C=C1)CC2=CC=CC=C2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O
|
||||
| InChI |
InChI=1S/C20H24O7/c1-25-14-8-6-12(7-9-14)10-13-4-2-3-5-15(13)26-20-19(24)18(23)17(22)16(11-21)27-20/h2-9,16-24H,10-11H2,1H3/t16-,17-,18+,19-,20-/m1/s1
|
||||
| InChIKey | HFLCZNNDZKKXCS-OUUBHVDSSA-N | ||||
| Pharmaceutical Properties | Xlogp | 1.6 | Rotatable Bond Count | 6 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Sophoraflavanone G Drug Info | ||||
| Xenobiotic Type | Investigative Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 72936 | ||||
| Docking Score | -9.024 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C25H28O6 | ||||
| Molecular Weight | 424.5 | ||||
| Canonical SMILES |
CC(=CC[C@H](CC1=C2C(=C(C=C1O)O)C(=O)C[C@H](O2)C3=C(C=C(C=C3)O)O)C(=C)C)C
|
||||
| InChI |
InChI=1S/C25H28O6/c1-13(2)5-6-15(14(3)4)9-18-20(28)11-21(29)24-22(30)12-23(31-25(18)24)17-8-7-16(26)10-19(17)27/h5,7-8,10-11,15,23,26-29H,3,6,9,12H2,1-2,4H3/t15-,23+/m1/s1
|
||||
| InChIKey | XRYVAQQLDYTHCL-CMJOXMDJSA-N | ||||
| Pharmaceutical Properties | Xlogp | 5.8 | Rotatable Bond Count | 6 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 6 | ||
| Xenobiotic Name | Kurarinone Drug Info | ||||
| Xenobiotic Type | Investigative Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 11982640 | ||||
| Docking Score | -8.962 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C26H30O6 | ||||
| Molecular Weight | 438.5 | ||||
| Canonical SMILES |
CC(=CC[C@H](CC1=C2C(=C(C=C1O)OC)C(=O)C[C@H](O2)C3=C(C=C(C=C3)O)O)C(=C)C)C
|
||||
| InChI |
InChI=1S/C26H30O6/c1-14(2)6-7-16(15(3)4)10-19-21(29)12-24(31-5)25-22(30)13-23(32-26(19)25)18-9-8-17(27)11-20(18)28/h6,8-9,11-12,16,23,27-29H,3,7,10,13H2,1-2,4-5H3/t16-,23+/m1/s1
|
||||
| InChIKey | LTTQKYMNTNISSZ-MWTRTKDXSA-N | ||||
| Pharmaceutical Properties | Xlogp | 5.6 | Rotatable Bond Count | 7 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.